Advanced functional architecture nutritional
immunoceutical platform
Discover ABIMPROSYC / PLPC-NX: The Revolution in Nutraceuticals, Supplements, and Immunoceuticals
Welcome to the forefront of biotechnological wellness! ABIMPROSYC / PLPC-NX is not just a supplement: it is a fourth-generation biostructural platform designed to redefine immune prevention, inflammation resolution, and longevity optimization. Developed by OGRD Alliance, this innovation positions ABIMPROSYC as a strategic leader in the holistic health ecosystem, delivering an unmatched medical-preventive standard.
What is ABIMPROSYC / PLPC-NX? ABIMPROSYC / PLPC-NX is an advanced biostructural architecture based on phospholipid-protein complexes (PLPC) optimized for immune modulation and cellular regeneration. Drawing on cutting-edge immunotherapy and biotechnology, this platform transforms traditional supplements into universal, high-efficacy solutions. Far from a mere blend of ingredients, it is a solvent line with validated functional density, focused on immune surveillance, oxidative stress control, and mitochondrial homeostasis, without therapeutic claims or prescription requirements.
Its technical core includes:
- Homogeneous high-bioavailability delivery: Stable liposomal matrices surpassing triphasic systems, ensuring optimal absorption.
- Ex vivo validation: Tested in human cellular models (THP-1, A375, PANC1) for suppression of pro-inflammatory markers, elevation of anti-inflammatory regulators, and oxidative control.
- Structured Phenotypic Traceability (STIP): Guarantees consistency and reproducibility across batches.
- Key components:
- Adaptogenic modulators for neuroendocrine stress resilience.
- Redox optimizers for activating antioxidant pathways (e.g., Nrf2).
- Detoxification activators via glutathione precursors.
- Autophagy inducers for tissue renewal.
- Senolytics for selective elimination of dysfunctional cells.
- Regenerative peptide matrices for structural integrity.
- Neuroimmune axis enhancers for circadian balance (GABAergic modulation).
ABIMPROSYC / PLPC-NX is a biotech-grade platform, reproducible and auditable, compliant with global standards like GRAS and Novel Foods, integrating functional synergies (e.g., IL-10 cytokine resolution) for a comprehensive approach.
Competitive Advantages: Why ABIMPROSYC / PLPC-NX Outshines the Competition? In a saturated market of conventional nutraceuticals, supplements, and immunoceuticals—often limited to first-generation formulas (basic vitamin or herbal blends with low bioavailability)—ABIMPROSYC / PLPC-NX leads the fourth generation with a disruptive approach. Here are its key advantages:
- Superior Generational Innovation: Competitors offer generic formulas with limited absorption. PLPC-NX integrates a functional density logic, optimizing vehicle stability (eliminating physicochemical instabilities) and minimizing interactions through precise dosing profiles. Result: Tangible, differentiated efficacy
- Cutting-Edge Scientific Validation: Unlike supplements relying on in vitro studies or marketing, PLPC-NX boasts ex vivo validation in human cellular models, proving inflammation suppression and redox homeostasis. This scientific rigor elevates it to a medical-preventive standard, surpassing competitors with weak evidence.
- Unmatched Bioavailability and Synergies: Most products deliver 20-50% absorption. PLPC-NX uses stable liposomal matrices for superior bioavailability (>90%), integrating pathways like Nrf2 (antioxidant defense) and IL-10 (inflammation resolution). Advantage: Faster, sustainable results in longevity, resilience, and cellular detoxification.
- Global Regulatory Compliance and Safety: Compliant with GRAS, Novel Foods, and equivalents, with auditable STIP traceability—a rarity in low-cost supplements. Free of regulatory risks or interactions, PLPC-NX is ideal for universal use, unlike competitors with unvalidated formulas or exaggerated claims.
- Holistic and Preventive Approach: While competitors target isolated symptoms, PLPC-NX optimizes the entire biological ecosystem: autophagy for tissue renewal, senolytics for clearing dysfunctional cells, and neuroimmune modulation for circadian balance. This makes it a strategic asset in biotechnological wellness, not just a supplement.
Conclusion ABIMPROSYC / PLPC-NX doesn’t compete—it redefines the standard. While others offer fragmented solutions, we deliver biotech-grade holistic prevention, backed by cutting-edge innovation and global regulatory compliance. It’s the choice for those seeking a longer, healthier, and more resilient life.
Ready to transform your wellness? Join the ABIMPROSYC / PLPC-NX revolution today! Contact us now and discover the future of health.
Advanced functional architecture nutritional immunoceutical platform
ABIMPROSYC is an international line of nutritional formulas designed to accompany complex physiological processes such as post-treatment immunoregulation, persistent inflammation, accelerated functional aging or neuroenergetic overload. Each product combines GRAS compounds with validated pharmacotechnical technologies, integrating liposomal capsules, functional capsules and sublingual tablets in a sequential structure of biphasic use (AM/PM).
WHAT IS ABIMPROSYC?
Fourth-Generation Nutritional
Immunoceutical Platform
Advanced structural architecture for biofunctional support in longevity, inflammation, immunomodulation, and adaptive recovery.
ABIMPROSYC is a line of scientifically structured nutritional formulas developed under the concept of a fourth-generation immunoceutical . Each product has been designed to support highly functional physiological processes without inducing pharmacological interference or therapeutic intent. Its structure combines GRAS ingredients with differentiated-release pharmacological technologies, delivered in
liposomal capsules, functional capsules
and sublingual tablets, according to the desired bioactive axis.
The compounds have been selected for their compatibility with redox regulation processes, immune surveillance, adaptive modulation, bioenergetic recovery, and cellular longevity, integrating a scientific narrative without clinical claims, but with functional traceability verified in ex vivo studies.
FOURTH GENERATION ARCHITECTURE
ABIMPROSYC responds to a clear technical-functional evolution:
- First generation : single-component vitamins
- Second generation : adaptogenic or basic polyphenolic extracts
- Third generation : liposomal combinations with targeted synergy
- Fourth generation : immunosuppressive platforms with structural validation, multiple capsules, encapsulated synbiotics and chronoadaptive release .
The ABIMPROSYC line represents a conceptual leap forward from traditional supplements, generic multivitamins, or unstructured adaptogens . Each formula is deliberately designed based on:
- Vehiculization by multiphasic liposomal matrix
- AM/PM release sequence adapted to physiological rhythms
- Inclusion of encapsulated symbiotics in a dry vegetable capsule, independent of the liquid phase
- Composition validated by functional families: polyphenols, mitochondrial cofactors, circadian modulators, structural lipids and redox antioxidants
These characteristics place it within the category of advanced nutritional immunoceuticals , with a technical orientation comparable to precision functional medicine regimens.
AVAILABLE FORMULAS ABIMPROSYC T-DEFENSE
Immunostructural support aimed at post-treatment cellular surveillance
Optimized functional core:
Liposomal matrix with Nrf2/ARE pathway inducers, highly stable redox epigenetic bioactives, CD8⁺/MHC-I axis modulators, long-chain resolving lipids, neuroimmune adaptogens and encapsulated symbiotics targeting the distal intestinal mucosa.
ABIMPROSYC REGENERATES
Functional modulation of persistent inflammatory processes and adaptive restoration
Optimized functional core: Anti-inflammatory
polyphenolic complex with bioavailable curcumins, redox-active immunonutrients, tissue remodeling compounds (low molecular weight collagen peptides) microencapsulated prebiotic-probiotic agents , and mitochondrial antioxidants stabilized in a biphasic emulsion.
ABIMPROSYC VITALIS
Biphasic architecture for functional longevity, circadian rhythm, and mitochondrial bioenergetics
Optimized functional core:
Biphasic system with NAD⁺ and PQQ precursors, mitochondrial biogenesis activators, neuroendocrine regulators (GABA–melatonin axis), intracellular lipophilic antioxidants, and epigenetically preserving circadian cofactors. Delivered in a sequentially released liposomal matrix.
ABIMPROSYC SPORT
Post-load recovery, neurometabolic activation and redox resilience without stimulants
Optimized Functional Core:
Triphasic adaptive formulation with mitochondrial fatty acid transporters, sports-grade buffered amino acids, HPA axis regulators synergized with endogenous GABA, post-exertion structural antioxidants, and biorhythmic release compounds for nighttime repair.
Each formula includes three different components per dose ( liposomal capsule , functional vegetable capsule, sublingual tablet), under an AM/PM regimen.
FUNCTIONAL VALIDATION AND REGULATORY SUPPORT
- All ingredients are listed under GRAS (21 CFR §170.30), Novel Food and/or NHP.
- The formulas do not exceed daily safety thresholds and have been designed without pharmacodynamic conflict or interaction with medications.
- Ex vivo studies have demonstrated reduction of IL-6 and TNF-α, increase of IL-10, reduction of ROS and maintained viability in cell models such as A375, PANC1 and THP-1
